Skip to main content

Month: May 2020

Aileron Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

Enrollment completed in the dose optimization part of the ongoing Phase 1b/2 clinical trial of ALRN-6924 as a chemoprotection agent in cancer patients– – –Scheduled to report interim results from the dose optimization part of the Phase 1b/2 trial 2nd Quarter 2020, and planning final data readout in the fourth quarter of 2020– – –Company implemented measures to reduce operating expenses to extend its cash runway to first quarter 2021– – –WATERTOWN, Mass., May 11, 2020 (GLOBE NEWSWIRE) — Aileron Therapeutics (NASDAQ:ALRN) today reported business highlights and financial results for the first quarter ended March 31, 2020.“We continue to advance ALRN-6924 as a chemoprotection agent for cancer patients, even as the world continues to face the ongoing coronavirus pandemic. We are extremely...

Continue reading

MTBC Appoints Division President of MTBC Force

Karl Johnson to Lead Division and Drive GrowthSOMERSET, N.J., May 11, 2020 (GLOBE NEWSWIRE) — MTBC, Inc. (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of cloud-based healthcare IT solutions and services, including telehealth, announced the appointment of Karl Johnson as division president of MTBC Force – the company’s new offering that helps industry vendors scale their services. MTBC Force has grown rapidly since its launch and is quickly becoming a market-leader in partner-services for healthcare IT and revenue cycle management vendors.“I’m excited for the opportunity to lead MTBC Force,” said Karl Johnson, Division President of MTBC Force. “We’ve already seen a tremendous response to our offering and I look forward to continuing to grow MTBC Force. Since so many vendors in our space lack the human capital and technology...

Continue reading

Cannabix Technologies Develops Version 2.0 of THC Breath Analyzer

VANCOUVER, British Columbia, May 11, 2020 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace, is pleased to report that the Company has developed a new version of its THC Breath Analyzer (“THCBA”) and is preparing for additional testing with the device. Company engineers have updated several components in the THCBA and have changed the form factor for improved handling. Cannabix Technologies is on the forefront in research and development to create point-of-care breath testing technologies for the detection of ∆9-tetrahydrocannabinol (“THC”) – the psychoactive component of marijuana that causes impairment. The THCBA incorporates microfluidic sensor technology for the detection of THC from breath....

Continue reading

Orbit International Corp. Reports April Bookings for Its Electronics Group in Excess of $1,850,000

HAUPPAUGE, N.Y., May 11, 2020 (GLOBE NEWSWIRE) — Orbit International Corp. (OTC PINK:ORBT), an electronics manufacturer and software solution provider, today announced that its Electronics Group’s (“OEG”) bookings for the month of April 2020 exceeded $1,850,000.         Bookings for the month of April 2020 were highlighted by a follow-on order of approximately $970,000 for keyboards used on a major military aviation program and a follow-on order received by our Q-Vio subsidiary for approximately $560,000 for a program for the U.S. Army. Other orders received during the quarter for the OEG consisted primarily of displays, control panels and repairs. Deliveries for contracts received during April have already commenced and are expected to continue through the second quarter of 2022. Mitchell Binder, President and CEO of Orbit International...

Continue reading

ArTara Therapeutics Announces Corporate Name Change to Protara Therapeutics

NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) — ArTara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company identifying and advancing transformative therapies for people with rare and specialty diseases, today announced that it has changed its name to Protara Therapeutics, Inc., effective immediately. As part of the name change, the Company has launched a new corporate website, www.protaratx.com. The Company’s shares will continue trading on the Nasdaq Capital Market under the ticker symbol “TARA.”“Our renaming both distinguishes Protara and reinforces our commitment to the patients we hope to serve by developing potentially transformative therapies,” said Jesse Shefferman, Chief Executive Officer of Protara. “With our diverse pipeline, we are pursuing multiple high-value opportunities in underserved areas, including a potential...

Continue reading

Colabor Announces the Closing of the Sale of Its Summit Foods Division in Ontario

BOUCHERVILLE, Quebec, May 11, 2020 (GLOBE NEWSWIRE) — Colabor Group Inc. (TSX: GCL) (“Colabor” or the “Company”) today announces it has closed the sale of most of the assets of its Summit Foods division (“Summit”) in Ontario to Flanagan Foodservice Inc.(“Flanagan”) for an aggregate amount of approximately $10 million, subject to post-closing adjustments.Colabor had announced last March the conclusion of an agreement to sell the majority of Summit’s assets to Flanagan, which was expected to close last month.  With the COVID-19 pandemic and the temporary closure of many businesses and restaurants, the necessity for Flanagan to operate the business with the Mississauga facility and its related equipment was no longer required.  The sale includes the independent and franchises restaurants business together with some assets and sales...

Continue reading

Colabor annonce la clôture de la vente de sa division Summit Foods en Ontario

BOUCHERVILLE, Québec, 11 mai 2020 (GLOBE NEWSWIRE) — Groupe Colabor Inc. (TSX : GCL) (« Colabor » ou la « Société ») annonce qu’elle a clôturé la vente de la majorité des actifs de sa division Summit Foods (« Summit ») en Ontario à Flanagan Foodservice inc. (« Flanagan ») pour un produit de vente d’environ 10 millions $, sujet à certains ajustements après la clôture.Colabor avait annoncé en mars dernier la conclusion d’un accord pour la vente de la majorité des actifs de Summit à Flanagan, qui devait se clôturer le mois dernier. Avec la pandémie COVID-19 et la fermeture temporaire de nombreux commerces et restaurants, Flanagan n’a plus besoin de l’installation de Mississauga et ses équipements connexes pour exploiter l’entreprise. La vente comprend les activités des restaurants indépendants et en franchise ainsi...

Continue reading

Little Green Pharma granted manufacturing permit from the Office of Drug Control

LGP granted Manufacture Permit by the Office of Drug ControlLGP plans to commence in-house extraction operations, reducing manufacturing costs and improving manufacturing efficienciesMONTRÉAL, May 11, 2020 (GLOBE NEWSWIRE) — Elixxer Ltd. (TSXV: ELXR)  (OTC-QB: ELIXF) (FRA: 2LQA) (“ELIXXER” or (the “Company”) is pleased to update that its pharmaceutical medical cannabis partner, Little Green Pharma (ASX:LGP) of Australia, has been granted a new Manufacture Permit over its manufacturing facility by Australia’s Office of Drug Control (“ODC”).The Manufacture Permit will allow LGP to manufacture cannabis extracts for supply to holders of Therapeutic Goods Administration (“TGA”) GMP manufacturing licences to produce finished medicinal cannabis products. The Company has an exclusive agreement with its TGA GMP-licenced Manufacturing Partner...

Continue reading

MamaMancini’s Launches Three Month National Marketing Campaign Highlighting Introduction of Plant-Based Meatballs Made with Beyond Beef ®

Company Estimates 4000 National Commercials to Reach over 50 Million Listeners on Sirius Xm RadioEAST RUTHERFORD, NJ, May 11, 2020 (GLOBE NEWSWIRE) — MamaMancini’s Holdings, Inc. (OTCQB: MMMB) (“MamaMancini’s” or the “Company”), a marketer of specialty pre-prepared, frozen and refrigerated food products, today announced the launch of a major national marketing campaign on Sirius XM Radio to promote MamaMancini’s new Plant-Based Meatballs and Sauce, made with Beyond Beef®, a plant-based ground meat made by Beyond Meat®.Starting on May 11, 2020, the campaign will air on an estimated 25 Sirius Xm channels with up to 4,000 commercials during the three month campaign period. Channels included on the campaign include Fox News, CNN, MSNBC, Fox Headline News, CNN HLN, Fox Business, Comedy Central, ESPN, Bloomberg, CNBC, and many more....

Continue reading

OSS Gen 4 PCIe Production Orders in 2020 Top $3.5 Million

ESCONDIDO, Calif., May 11, 2020 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (Nasdaq: OSS) has received more than $3.5 million in production orders for its new Gen 4 PCIe products from multiple OEM customers for delivery in 2020. As the first company to introduce Gen 4-based components to the market, the orders demonstrate OSS’ continued leadership in high-performance edge computing.The Gen 4 PCIe production orders include those placed by a market leader in NVMe flash memory testing and validation tools. The customer plans to incorporate two OSS Gen 4 PCIe cable adapters and an OSS Gen 4 backplane in its testing equipment. The equipment will ultimately be used by Tier 1 NVMe flash memory vendors that provide high-performance SSD storage for the next generation of gaming laptops, mobile workstations, public and private cloud datacenter...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.